PD-L1 is a key immune checkpoint protein that, when expressed on the surface of tumor cells, interacts with the PD-1 receptor on T cells, leading to immune suppression and allowing tumor cells to evade immune detection. The gene discussed is CD274; the disease is neoplasm.